Insider Transactions in Q2 2022 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 23
2022
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Open market or private sale
|
Direct |
1,081
-0.33%
|
$8,648
$8.93 P/Share
|
|
May 20
2022
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,200
-0.66%
|
$17,600
$8.74 P/Share
|
|
May 20
2022
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
3,947
-1.02%
|
$31,576
$8.74 P/Share
|
|
May 20
2022
|
Andrew A. Hindman SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,365
-0.7%
|
$26,920
$8.74 P/Share
|
|
May 20
2022
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
11,025
-0.76%
|
$88,200
$8.74 P/Share
|
|
Apr 26
2022
|
Alsup Laurie Smaldone |
BUY
Grant, award, or other acquisition
|
Direct |
9,852
+18.07%
|
-
|
|
Apr 26
2022
|
Eran Broshy |
BUY
Grant, award, or other acquisition
|
Direct |
9,852
+13.93%
|
-
|
|
Apr 26
2022
|
Burton G Malkiel |
BUY
Grant, award, or other acquisition
|
Direct |
9,852
+9.72%
|
-
|
|
Apr 26
2022
|
Dean J Mitchell |
BUY
Grant, award, or other acquisition
|
Direct |
9,852
+13.93%
|
-
|
|
Apr 26
2022
|
Donal O'Connor |
BUY
Grant, award, or other acquisition
|
Direct |
9,852
+15.46%
|
-
|
|
Apr 26
2022
|
Deepika Pakianathan |
BUY
Grant, award, or other acquisition
|
Direct |
9,852
+26.2%
|
-
|
|
Apr 26
2022
|
William D Young |
BUY
Grant, award, or other acquisition
|
Direct |
9,852
+11.21%
|
-
|